Andrew J. Flint
Keine laufenden Positionen mehr
Profil
Andrew J.
Flint joined CEPTYR, Inc. in 1996 and currently serves as Director of Biochemical and Cellular Pharmacology.
He was a Fellow at the Cancer Research Institute and the F.M.
Kirby Foundation from 1991 to 1996.
Dr. Flint received a BS degree in Chemistry with honors from the University of North Carolina in 1984 and a PhD in Biochemistry from the University of California, Berkeley in 1990.
Ehemalige bekannte Positionen von Andrew J. Flint
| Unternehmen | Position | Ende |
|---|---|---|
CEPTYR, Inc.
 CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | Corporate Officer/Principal | 01.03.2009 |
Cancer Research Institute
 Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Corporate Officer/Principal | - |
| F.M. Kirby Foundation, Inc. | Corporate Officer/Principal | 01.01.1996 |
Ausbildung von Andrew J. Flint
| University of California, Berkeley | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
CEPTYR, Inc.
CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | Health Technology |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Health Services |
| F.M. Kirby Foundation, Inc. |
